Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
A critical review of new treatments for the myelodysplastic syndromes
Gerardo Colón-Otero
Hematology / Oncology / Cancer Center / Breast Clinic
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A critical review of new treatments for the myelodysplastic syndromes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Myelodysplastic Syndromes
100%
Peripheral Blood Stem Cells
44%
Bone Marrow
38%
Acute Myeloid Leukemia
33%
Amifostine
26%
Refractory Anemia
25%
Cytidine
24%
Topotecan
24%
Azacitidine
23%
Pentoxifylline
23%
Decitabine
22%
Antilymphocyte Serum
22%
Homologous Transplantation
20%
Erythropoietin
18%
Ciprofloxacin
18%
DNA Methylation
17%
Quality Improvement
17%
Dexamethasone
16%
Therapeutics
14%
Leukemia
14%
Quality of Life
11%
Transplants
11%
Cytokines
10%
T-Lymphocytes
10%
Apoptosis
10%
Morbidity
10%
Drug Therapy
10%
DNA
9%
Incidence
8%